• Blueprint Medicines Co. (NASDAQ:BPMC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 30 Jan 2025 01:45:19   America/Chicago


    Blueprint Medicines Co. (NASDAQ:BPMC) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 30, 2025 Share Link copied to clipboard. Blueprint Medicines Co. ( NASDAQ:BPMC - Get Free Report ) has ear
    Read more...
Share on,